lilly oral glp 1 The Food and Drug Administration has approved the first GLP-1 weight loss drug by Eli Lilly, called Foundayo Eli Lilly's Oral GLP-1 Breakthrough

Ive really only mentioned the biggest con of GLP-1 agonists which is a potential risk of thyroid cancer but there are others to consider such as muscle loss as well

I like the work, I like watching the numbers crawl up, and I love being fitter than I ever was at 30 or 40

The hormone increases insulin secretion and improves insulin sensitivity

Eric Topol (30:55): Well, what's interesting is we're pretty close friends, and he, not only that paper you mentioned on organ clocks, which is a phenomenal contribution, but he has a paper coming out soon in Nature Medicine, the preprint is up, and what he showed was that the brain and the immune system was the main organ clocks that were associated with longevity

48 Initial evaluation in healthy humans revealed that oral administration of Danuglipron produced a dose-dependent increase in systemic exposure bioavailability

Additional Benefits of GLP-1 RA Cardiovascular outcomes trials have demonstrated additional benefits of this medication class in T2DM patients, most notably a reduction in cardiovascular events for patients with established atherosclerotic cardiovascular disease (ASCVD) and those at higher ASCVD risk